Diabetes

Pharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.

The management of type 1 and type 2 diabetes is a booming area of research and development, and the pipeline contains many innovative drugs and dosage forms.

Individuals with diabetes should not overlook preventive skin care as part of their diabetes management routine.

Getting patients who have diabetes -- or who are at risk -- to make proactive changes is difficult, but it's not impossible.

Pharmacists should be prepared to offer informed counseling and ongoing support to the increasing numbers of American women who are obese and trying to lose weight.

Cycloset (quick-release formulation of bromocriptine mesylate), a dopamine D2 agonist, is a novel agent recently approved by the FDA for type 2 diabetes mellitus.

Keeping diabetes under control has many benefits, including cutting the risk for cardiovascular events such as coronary artery disease, myocardial infraction, and congestive heart failure.

Patients with diabetes are at increased risk for cavities, gingivitis, periodontal disease, xerostomia, salivary gland problems, and infections. Pharmacists can help patients develop good oral care habits to lower their risk.

Patients with diabetes are at increased risk for cavities, gingivitis, periodontal disease, xerostomia, salivary gland problems, and infections. Pharmacists can help patients develop good oral care habits to lower their risk.